Table of Contents
Editor's Note
Published Date: Mar 27, 2026Company dynamics
- On 17 March, 2026, Huaheng Biotechnology released its 2025 annual report.
- On 14 March, 2026, Boen Group announced that it intends to utilize up to USD30.33 million (RMB210 million) of temporarily idle raised funds for cash management purposes.
- On 7 March, 2026, Adisseo released its 2025 results.
- On 4 March, 2026, Garden Bio announced the temporary shutdown of the cholesterol production line at its wholly-owned subsidiary, Garden Nutrition.
Project progress
- On 17 March, 2026, the completion environmental protection acceptance monitoring report for the alfacalcidol API R&D project of was published.
- On 10 March, 2026, the EI report of Yuxing Biotechnology's 50,000 t/a betaine project was accepted.
- On 6 March, 2026, the EI report for Zhongshan Anshi's new Vitamin D3 powder workshop and pharmaceutical production lines technical transformation project was accepted.
The USD/RMB exchange rate in this Report is USD1.00=CNY6.9236 on 2 March, 2026, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Governmental Direction
Published Date: Mar 19, 2026
Please purchase to view
Market Analysis
Published Date: Mar 19, 2026 Company Dynamics
Published Date: Mar 19, 2026 Price Update
Published Date: Mar 19, 2026 Import and Export
Published Date: Mar 19, 2026 News in Brief
Published Date: Mar 19, 2026
Buy Now
Add to cart
